ecteribulin,eribulin mesylate,farletuzumab
eisai,eisai pharmaceutical,bms
['eribulin', 'farletuzumab,ecteribulin', 'farletuzumab', 'eisai']
#eisai presents new findings for #antibodydrugconjugate #farletuzumabecteribulin at #asco22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.